Zepp Health ( (ZEPP) ) has issued an announcement.
Zepp Health Corporation reported its unaudited financial results for the fourth quarter and full year of 2024, revealing a 40.2% quarter-over-quarter revenue increase, driven by the success of Amazfit-branded products, particularly the T-Rex 3. Despite macroeconomic challenges, the company achieved a gross margin of 38.5% for the year, up from 26.2% in 2023, and maintained a robust cash position of $111 million. The company is optimistic about future growth, bolstered by strategic partnerships, product launches, and advancements in technology, including the integration of OpenAI 4.5 in Zepp OS. Zepp Health’s focus on enhancing brand influence and expanding market share, especially in emerging markets, is expected to continue driving sales and profitability.
More about Zepp Health
Zepp Health Corporation operates in the technology and health industry, primarily focusing on the development and production of smart wearable devices. Their product line includes the Amazfit brand, which is known for its smartwatches and fitness trackers. The company targets both the consumer electronics market and the health and fitness sector, with a significant presence in emerging markets.
YTD Price Performance: 4.53%
Average Trading Volume: 21,855
Technical Sentiment Signal: Buy
Current Market Cap: $47.09M
For an in-depth examination of ZEPP stock, go to TipRanks’ Stock Analysis page.